Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment
- PMID: 29467711
- PMCID: PMC5807658
- DOI: 10.3389/fneur.2018.00031
Eye Movement Abnormalities in Multiple Sclerosis: Pathogenesis, Modeling, and Treatment
Abstract
Multiple sclerosis (MS) commonly causes eye movement abnormalities that may have a significant impact on patients' disability. Inflammatory demyelinating lesions, especially occurring in the posterior fossa, result in a wide range of disorders, spanning from acquired pendular nystagmus (APN) to internuclear ophthalmoplegia (INO), among the most common. As the control of eye movements is well understood in terms of anatomical substrate and underlying physiological network, studying ocular motor abnormalities in MS provides a unique opportunity to gain insights into mechanisms of disease. Quantitative measurement and modeling of eye movement disorders, such as INO, may lead to a better understanding of common symptoms encountered in MS, such as Uhthoff's phenomenon and fatigue. In turn, the pathophysiology of a range of eye movement abnormalities, such as APN, has been clarified based on correlation of experimental model with lesion localization by neuroimaging in MS. Eye movement disorders have the potential of being utilized as structural and functional biomarkers of early cognitive deficit, and possibly help in assessing disease status and progression, and to serve as platform and functional outcome to test novel therapeutic agents for MS. Knowledge of neuropharmacology applied to eye movement dysfunction has guided testing and use of a number of pharmacological agents to treat some eye movement disorders found in MS, such as APN and other forms of central nystagmus.
Keywords: eye movements; internuclear ophthalmoplegia; multiple sclerosis; nystagmus; pathologic saccades.
Figures


Similar articles
-
Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.Ann N Y Acad Sci. 2011 Sep;1233:313-9. doi: 10.1111/j.1749-6632.2011.06125.x. Ann N Y Acad Sci. 2011. PMID: 21951010
-
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis.Prog Brain Res. 2019;249:329-344. doi: 10.1016/bs.pbr.2019.04.021. Epub 2019 Jun 6. Prog Brain Res. 2019. PMID: 31325992
-
Vestibulo-ocular reflex deficits with medial longitudinal fasciculus lesions.J Neurol. 2017 Oct;264(10):2119-2129. doi: 10.1007/s00415-017-8607-8. Epub 2017 Sep 6. J Neurol. 2017. PMID: 28879396
-
Ocular Motor Manifestations of Multiple Sclerosis.J Neuroophthalmol. 2017 Sep;37(3):332-340. doi: 10.1097/WNO.0000000000000507. J Neuroophthalmol. 2017. PMID: 28410279 Review.
-
Internuclear ophthalmoplegia: pathophysiology and diagnosis.Baillieres Clin Neurol. 1992 Aug;1(2):455-70. Baillieres Clin Neurol. 1992. PMID: 1344079 Review.
Cited by
-
Dynamic accommodation measurement using Purkinje reflections and machine learning.Sci Rep. 2023 Dec 7;13(1):21625. doi: 10.1038/s41598-023-47572-0. Sci Rep. 2023. PMID: 38062067 Free PMC article.
-
The Role of Vitamins in Neurodegenerative Disease: An Update.Biomedicines. 2021 Sep 22;9(10):1284. doi: 10.3390/biomedicines9101284. Biomedicines. 2021. PMID: 34680401 Free PMC article. Review.
-
Oculomotor analysis to assess brain health: preliminary findings from a longitudinal study of multiple sclerosis using novel tablet-based eye-tracking software.Front Neurol. 2023 Sep 6;14:1243594. doi: 10.3389/fneur.2023.1243594. eCollection 2023. Front Neurol. 2023. PMID: 37745656 Free PMC article.
-
Alleviation of extensive visual pathway dysfunction by a remyelinating drug in a chronic mouse model of multiple sclerosis.Brain Pathol. 2021 Mar;31(2):312-332. doi: 10.1111/bpa.12930. Epub 2021 Jan 29. Brain Pathol. 2021. PMID: 33368801 Free PMC article.
-
Metabolic costs of walking and arm reaching in persons with mild multiple sclerosis.J Neurophysiol. 2023 Apr 1;129(4):819-832. doi: 10.1152/jn.00373.2022. Epub 2023 Mar 8. J Neurophysiol. 2023. PMID: 36883754 Free PMC article.
References
-
- Meyer-Moock S, Feng Y-S, Maeurer M, Dippel F-W, Kohlmann T. Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the multiple sclerosis functional composite (MSFC) in patients with multiple sclerosis. BMC Neurol (2014) 4:58.10.1186/1471-2377-14-58 - DOI - PMC - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous